Grown Rogue International (GRUSF) Enterprise Value (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Enterprise Value came in at -$7.3 million in Q1 2026, up 2.69% year-on-year from -$7.1 million in Q1 2025, and up 12.68% quarter-over-quarter from -$8.4 million in Q4 2025.
Grown Rogue International (GRUSF) Enterprise Value (2009 - 2026) Analysis & Trends
Grown Rogue International's Enterprise Value history runs 18 years deep, the most recent figure standing at -$7.3 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 2.69% year-over-year to -$7.3 million in Q1 2026; TTM through Mar 2026 was -$7.3 million, a 2.69% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, down 366.88% from the prior year.
- Enterprise Value climbed to -$7.3 million in Q1 2026 per GRUSF's latest filing, from -$8.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at $2.0 million in Q4 2022 and bottomed at -$9252242000.0 billion in Q2 2025.
- The 5-year median for Enterprise Value is -$5.0 million (2024), against an average of -$578266200.4 billion.
- Across the five-year window, Enterprise Value surged 74.8% in 2022 and sank 197438443923367.38% in 2025, its largest moves.
- Year by year, Enterprise Value stood at $2.0 million in 2022, then plunged by 312.01% to -$4.3 million in 2023, then soared by 59.52% to -$1.7 million in 2024, then tumbled by 385.35% to -$8.4 million in 2025, then advanced by 12.68% to -$7.3 million in 2026.
- Per Business Quant, the three latest GRUSF Enterprise Value figures stand at -$7.3 million (Q1 2026), -$8.4 million (Q4 2025), and -$17206.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.30 Mn |
| Dec 31, 2025 | -8.36 Mn |
| Sep 30, 2025 | -17,206.38 Bn |
| Jun 30, 2025 | -9,252,242,000.00 Bn |
| Mar 31, 2025 | -7.50 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | -3.36 Mn |
| Jun 30, 2024 | -4.69 Mn |
| Mar 31, 2024 | -5.37 Mn |
| Dec 31, 2023 | -4.25 Mn |
| Oct 31, 2023 | -5.55 Mn |
| Jul 31, 2023 | -6.36 Mn |
| Apr 30, 2023 | -3.02 Mn |
| Jan 31, 2023 | -808,796.00 |
| Oct 31, 2022 | 2.01 Mn |
| Jan 31, 2022 | -1.11 Mn |
| Oct 31, 2021 | 1.15 Mn |
| Jul 31, 2021 | -217,788.00 |
| Apr 30, 2021 | -1.76 Mn |
| Jan 31, 2021 | -931,888.00 |